Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic

Jurjen J. Luykx; Sisco M.P. van Veen; Arne Risselada; Paul Naarding; Joeri K. Tijdink; Christiaan H. Vinkers

doi:10.1192/bjp.2020.92

Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic

Jurjen J. Luykx
, Sisco M.P. van Veen
, Arne Risselada
, Paul Naarding
, Joeri K. Tijdink
, Christiaan H. Vinkers

Research output: Contribution to journal › Review article › peer-review

5 Downloads (Pure)

Abstract

Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.

Original language	English
Pages (from-to)	471-474
Number of pages	4
Journal	The British journal of psychiatry : the journal of mental science
Volume	217
Issue number	3
DOIs	https://doi.org/10.1192/bjp.2020.92
Publication status	Published - 1 Sept 2020

Keywords

COVID-19
epidemiology
prescribing
psychiatry
psychopharmacology

Access to Document

10.1192/bjp.2020.92

safe-and-informed-prescribing-of-psychotropic-medication-during-the-covid-19-pandemicFinal published version, 341 KB

Cite this

@article{70685f9d19c74d9a8ca73e25c05b44a2,

title = "Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic",

abstract = "Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.",

keywords = "COVID-19, epidemiology, prescribing, psychiatry, psychopharmacology",

author = "Luykx, \{Jurjen J.\} and \{van Veen\}, \{Sisco M.P.\} and Arne Risselada and Paul Naarding and Tijdink, \{Joeri K.\} and Vinkers, \{Christiaan H.\}",

note = "Publisher Copyright: Copyright {\textcopyright} The Authors 2020. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = sep,

day = "1",

doi = "10.1192/bjp.2020.92",

language = "English",

volume = "217",

pages = "471--474",

journal = "The British journal of psychiatry : the journal of mental science",

issn = "0007-1250",

publisher = "Cambridge University Press",

number = "3",

}

TY - JOUR

T1 - Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic

AU - Luykx, Jurjen J.

AU - van Veen, Sisco M.P.

AU - Risselada, Arne

AU - Naarding, Paul

AU - Tijdink, Joeri K.

AU - Vinkers, Christiaan H.

N1 - Publisher Copyright: Copyright © The Authors 2020. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/9/1

Y1 - 2020/9/1

N2 - Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.

AB - Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.

KW - COVID-19

KW - epidemiology

KW - prescribing

KW - psychiatry

KW - psychopharmacology

UR - https://www.scopus.com/pages/publications/85090003086

U2 - 10.1192/bjp.2020.92

DO - 10.1192/bjp.2020.92

M3 - Review article

C2 - 32362299

AN - SCOPUS:85090003086

SN - 0007-1250

VL - 217

SP - 471

EP - 474

JO - The British journal of psychiatry : the journal of mental science

JF - The British journal of psychiatry : the journal of mental science

IS - 3

ER -

Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this